ATM deficiency is related to a high incidence of tissue malignancies [18–20] and ATM-deficient tumors cells are sensitive to poly (ADP-ribose) polymerase-1 (PARP) inhibition, a potential target which has been proposed for the treatment of GC in several previous studies [21–24]. This evidence concerns the gene ATM and gastric cancer.